Microvision (MVIS) Board Member Yalon Farhi to Retire
Get Alerts MVIS Hot Sheet
Join SI Premium – FREE
MicroVision, Inc. (NASDAQ: MVIS) announced that Yalon Farhi will not stand for re-election to the board of directors and will step down when his current term expires at the Company’s 2021 annual meeting of shareholders.
Yalon Farhi joined the Board in September 2016 and is stepping down to pursue personal business interests. Farhi, a Colonel in the Israeli Defense Forces (reserves), has served as a motivational lecturer and educator at Bnei-David Institutions, a pre-army and post-army educational program in Israel and has served on the board of directors of DarioHealth Corp., a provider of digital health services and dynaCERT, Inc. a Canadian company that provides carbon reduction technology for internal combustion engines.
“Yalon Farhi has been a valuable member of the board since he joined in 2016,” said Brian Turner, Chairman and Independent Director at MicroVision. “We have benefitted from Yalon’s expertise in international business and appreciate his insight and contributions to the board and the Company. I have enjoyed working with him and wish him well on his future pursuits.”
“I am grateful to have been able to serve on the MicroVision board and contribute to the evolution of the Company,” said Yalon Farhi. “I will miss working with my fellow board members and management but believe the time is right to not stand for re-election and retire from the Board when my term ends to enable me to focus on personal business opportunities. I remain excited about the Company’s future.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Glass Lewis backs MicroVision shareholder proposals ahead of July meeting
- Kymera Therapeutics names Felix Baker as board chairman
- Freedom Bank appoints Sheila Stabile to its board of directors
Create E-mail Alert Related Categories
Board ChangesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share